Skip to content
Log in Join free
The ReProgram cover art

Dr. George Murphy

The ReProgram

A Life Sciences and Science podcast

#74 in Life Sciences · 🇦🇺 #95 in Life Sciences · 🇸🇪
Good podcast? Give it some love!

About the show

The ReProgram is dedicated to exploring how we can extend the healthy human lifespan through science and self-understanding. Hosted by Dr. George Murphy, each episode dives into the rapidly evolving fields of aging biology, longevity, regenerative medicine, and geroscience. From cellular rejuvenation and advanced therapeutics to lifestyle strategies that build resilience against disease, we examine what the science actually shows—and what it doesn’t. No hype. No myths. Just rigorous, evidence-based conversations about how we can reprogram our biology to live longer and healthier lives.

Newest episodes

Resveratrol and Longevity: What Does the Human Evidence Show?

16 min

🎬 EPISODE OVERVIEW Does resveratrol live up to the longevity hype? We examine the clinical data to see if it actually improves health markers.Research into this supplement often focuses on molecular changes, but we look at how resveratrol impacts real-world patient outcomes. By analyzing studies on cardiovascular health, inflammation, and cognitive function, we distinguish between theoretical benefits and proven clinical results. This scorecard provides a clear framework for evaluating whether the current evidence justifies its use as a longevity intervention.We also compare how different patient groups respond to this compound, highlighting where the data remains inconclusive. Understanding these limitations is essential for anyone trying to separate marketing claims from rigorous science. This analysis is for those who prioritize evidence-based health decisions over popular trends.If you value longevity science without the hype, subscribe to The ReProgram. 🔑 KEYWORDS Resveratrol • Longevity • Human Trials • Healthy Aging • Evidence Scorecard • Supplements 📌 KEY TAKEAWAYS • Changes in selected markers do not establish longer human life. • Study population, dose and outcome shape what a finding means. • Better cognitive test scores do not demonstrate dementia prevention. • Natural origin does not settle safety or medication interactions. • Ask what was measured, in whom, and whether the benefit matters. 🎙️ THE REPROGRAM PERSPECTIVEA molecule can be biologically interesting while its value as an everyday supplement remains uncertain. We should be able to hold both ideas at once. The score can change when the evidence changes. ⏱️ CHAPTERS 00:00 Resveratrol and its claims 01:09 How the scorecard works 02:04 Biology and the early animal studies 03:38 Absorption and exposure 04:08 Metabolic markers 05:52 Cardiovascular claims 06:36 The exercise trial 07:39 Cognition and dementia distinctions 09:40 Inflammatory markers 11:08 Human lifespan 12:01 Safety and drug interac...

Can We Reverse Aging in Humans? What the First Results Really Show

26 min

🎬 EPISODE OVERVIEW Can we reverse aging? We examine what recent clinical announcements actually prove about the state of human longevity science.Recent reports regarding partial cellular reprogramming have sparked debate about the potential for human age reversal. We break down the distinction between clinical benefit and actual tissue rejuvenation, focusing on what early findings from human trials really indicate. By separating marketing claims from biological reality, we clarify how these interventions affect cellular function.Understanding the limits of current research is vital for anyone interested in healthy aging. We analyze why improvements in specific metrics, such as visual-field tests, do not necessarily equate to a universal reset of the aging process. This assessment provides a grounded look at how we measure progress in the field of longevity and what future experiments must demonstrate to validate these early observations.If you value longevity science without the hype, subscribe to The ReProgram. 🔑 KEYWORDS Partial Reprogramming • ER-100 • OSK • Epigenetics • Glaucoma • Cell Identity • Aging Clocks • Healthspan 📌 KEY TAKEAWAYS • Partial reprogramming aims to change cellular state while preserving specialized function. • Early observations in three participants justify further study, not a conclusion of human age reversal. • Improvement at visual-field test locations is not a percentage gain in overall vision. • Control of gene expression does not establish that every downstream effect is reversible. • Durable patient benefit, controlled comparisons, and replication matter more than a younger-looking test alone. 🎙️ THE REPROGRAM PERSPECTIVE A treatment can be a major medical advance without proving that aging has been reversed.The goal is useful function, resilience, and more time living well. Hope and demanding scientific questions belong together. ⏱️ CHAPTERS 00:00 Can we reverse aging—and what would count? 01:30 The ReProgram opening 01:38 Parti...

What Centenarians Reveal About Food and Aging | Dr. Paola Sebastiani

35 min

🎬 EPISODE OVERVIEW Can you actually eat like a centenarian to extend your life? We examine the evidence behind dietary habits and aging.Dr. Paola Sebastiani joins us to discuss the complexities of longevity science and why the current diet of someone who has lived to 100 may not reflect the factors that helped them reach that age. We unpack how metabolomics provides clues about physiological decline, while emphasizing that a single blood marker does not establish cause and effect for long-term health.Our conversation addresses common myths regarding protein intake and the role of genetics in exceptional longevity. By analyzing the data from the New England Centenarian Study, we separate biological mechanisms from marketing claims to understand what truly supports healthy aging. We also look at the limitations of biological age tests and why standardization remains a critical challenge in current research.If you value longevity science without the hype, subscribe to The ReProgram for weekly evidence-based breakdowns. What is one belief about food and aging you would be willing to reconsider? 👤 ABOUT THE SPEAKER Dr. Paola Sebastiani is a Professor at Tufts University School of Medicine and Director of the Tufts CTSI Biostatistics, Epidemiology, and Research Design Center. A biostatistician studying genetics and exceptional longevity, she and her group lead data analyses for the New England Centenarian Study. Official profile: https://disc.tufts.edu/paola-sebastiani 🔑 KEYWORDS Paola Sebastiani • Centenarians • Nutrition • Metabolomics • Protein • Healthy Aging • Longevity Genetics • Biological Age 📌 KEY TAKEAWAYS • Metabolites offer clues about aging, but a blood marker does not by itself establish cause and effect. • A centenarian’s current diet may differ from the diet they followed decades earlier. Longitudinal studies matter. • Protein findings from animal studies do not automatically translate to older adults. Sebastiani also cautions against assuming more is...

Similar podcasts

All episodes

Resveratrol and Longevity: What Does the Human Evidence Show?

16 min

🎬 EPISODE OVERVIEW Does resveratrol live up to the longevity hype? We examine the clinical data to see if it actually improves health markers.Research into this supplement often focuses on molecular changes, but we look at how resveratrol impacts real-world patient outcomes. By analyzing studies on cardiovascular health, inflammation, and cognitive function, we distinguish between theoretical benefits and proven clinical results. This scorecard provides a clear framework for evaluating whether the current evidence justifies its use as a longevity intervention.We also compare how different patient groups respond to this compound, highlighting where the data remains inconclusive. Understanding these limitations is essential for anyone trying to separate marketing claims from rigorous science. This analysis is for those who prioritize evidence-based health decisions over popular trends.If you value longevity science without the hype, subscribe to The ReProgram. 🔑 KEYWORDS Resveratrol • Longevity • Human Trials • Healthy Aging • Evidence Scorecard • Supplements 📌 KEY TAKEAWAYS • Changes in selected markers do not establish longer human life. • Study population, dose and outcome shape what a finding means. • Better cognitive test scores do not demonstrate dementia prevention. • Natural origin does not settle safety or medication interactions. • Ask what was measured, in whom, and whether the benefit matters. 🎙️ THE REPROGRAM PERSPECTIVEA molecule can be biologically interesting while its value as an everyday supplement remains uncertain. We should be able to hold both ideas at once. The score can change when the evidence changes. ⏱️ CHAPTERS 00:00 Resveratrol and its claims 01:09 How the scorecard works 02:04 Biology and the early animal studies 03:38 Absorption and exposure 04:08 Metabolic markers 05:52 Cardiovascular claims 06:36 The exercise trial 07:39 Cognition and dementia distinctions 09:40 Inflammatory markers 11:08 Human lifespan 12:01 Safety and drug interac...

Can We Reverse Aging in Humans? What the First Results Really Show

26 min

🎬 EPISODE OVERVIEW Can we reverse aging? We examine what recent clinical announcements actually prove about the state of human longevity science.Recent reports regarding partial cellular reprogramming have sparked debate about the potential for human age reversal. We break down the distinction between clinical benefit and actual tissue rejuvenation, focusing on what early findings from human trials really indicate. By separating marketing claims from biological reality, we clarify how these interventions affect cellular function.Understanding the limits of current research is vital for anyone interested in healthy aging. We analyze why improvements in specific metrics, such as visual-field tests, do not necessarily equate to a universal reset of the aging process. This assessment provides a grounded look at how we measure progress in the field of longevity and what future experiments must demonstrate to validate these early observations.If you value longevity science without the hype, subscribe to The ReProgram. 🔑 KEYWORDS Partial Reprogramming • ER-100 • OSK • Epigenetics • Glaucoma • Cell Identity • Aging Clocks • Healthspan 📌 KEY TAKEAWAYS • Partial reprogramming aims to change cellular state while preserving specialized function. • Early observations in three participants justify further study, not a conclusion of human age reversal. • Improvement at visual-field test locations is not a percentage gain in overall vision. • Control of gene expression does not establish that every downstream effect is reversible. • Durable patient benefit, controlled comparisons, and replication matter more than a younger-looking test alone. 🎙️ THE REPROGRAM PERSPECTIVE A treatment can be a major medical advance without proving that aging has been reversed.The goal is useful function, resilience, and more time living well. Hope and demanding scientific questions belong together. ⏱️ CHAPTERS 00:00 Can we reverse aging—and what would count? 01:30 The ReProgram opening 01:38 Parti...

What Centenarians Reveal About Food and Aging | Dr. Paola Sebastiani

35 min

🎬 EPISODE OVERVIEW Can you actually eat like a centenarian to extend your life? We examine the evidence behind dietary habits and aging.Dr. Paola Sebastiani joins us to discuss the complexities of longevity science and why the current diet of someone who has lived to 100 may not reflect the factors that helped them reach that age. We unpack how metabolomics provides clues about physiological decline, while emphasizing that a single blood marker does not establish cause and effect for long-term health.Our conversation addresses common myths regarding protein intake and the role of genetics in exceptional longevity. By analyzing the data from the New England Centenarian Study, we separate biological mechanisms from marketing claims to understand what truly supports healthy aging. We also look at the limitations of biological age tests and why standardization remains a critical challenge in current research.If you value longevity science without the hype, subscribe to The ReProgram for weekly evidence-based breakdowns. What is one belief about food and aging you would be willing to reconsider? 👤 ABOUT THE SPEAKER Dr. Paola Sebastiani is a Professor at Tufts University School of Medicine and Director of the Tufts CTSI Biostatistics, Epidemiology, and Research Design Center. A biostatistician studying genetics and exceptional longevity, she and her group lead data analyses for the New England Centenarian Study. Official profile: https://disc.tufts.edu/paola-sebastiani 🔑 KEYWORDS Paola Sebastiani • Centenarians • Nutrition • Metabolomics • Protein • Healthy Aging • Longevity Genetics • Biological Age 📌 KEY TAKEAWAYS • Metabolites offer clues about aging, but a blood marker does not by itself establish cause and effect. • A centenarian’s current diet may differ from the diet they followed decades earlier. Longitudinal studies matter. • Protein findings from animal studies do not automatically translate to older adults. Sebastiani also cautions against assuming more is...

Omega-3 Fish Oil: What Does the Evidence Actually Support?

16 min

🎬 EPISODE OVERVIEW Does your fish oil capsule deserve its reputation? In Episode 31, I review omega-3s for heart health, cognition, and healthy aging, then give five evidence scores and an overall C+.We examine VITAL, REDUCE-IT, STRENGTH, newer DHA research, aging clocks, and safety. Eating fish, taking supplements, and using prescription omega-3s are different questions. 🔑 KEYWORDS Omega-3 • Fish Oil • EPA • DHA • Triglycerides • Cognition • Aging Clocks • Atrial Fibrillation • Longevity 📌 KEY TAKEAWAYS • Triglyceride lowering: 5/5 at studied therapeutic doses. • Routine cardiovascular prevention in generally healthy adults: 2/5. Prescription EPA in selected high-risk patients is a separate clinical decision. • Preventing cognitive decline in generally healthy older adults: 1/5. • Epigenetic aging clocks: 2/5. Small changes in clock estimates do not establish longer life. • Extending human lifespan through routine supplementation: 1/5. • Overall: C+ for routine OTC fish oil as a healthy-aging intervention; this is my assessment, not a mathematical average. Dose, formulation, and baseline risk matter. 🎙️ THE REPROGRAM PERSPECTIVE A biological mechanism or improved test result is a starting point. Ask whether the evidence shows better health, function, or survival in people like you. Educational discussion; understand prescribed treatment with your clinician before making changes. ⏱️ CHAPTERS 00:00 What has fish oil earned? 00:55 The Scorecard framework 01:16 Fish, supplements, and prescription products 01:56 Read the EPA and DHA label 02:27 Triglycerides: the strongest evidence 03:43 VITAL and heart prevention 04:39 REDUCE-IT and prescription EPA0 5:50 STRENGTH and conflicting results 07:08 Brain health and the DHA trials 08:34 DO-HEALTH and aging clocks 09:59 Heart-rhythm risk and interactions 11:37 Five claims, five scores 13:22 The C+ verdict and its limits 14:27 Questions to ask about your supplement 15:31 Closing perspective 💬 JOIN THE CONVERSATION If you t...

Can We Really Measure and Reverse Aging? | Steve Horvath

21 min

🎬 EPISODE OVERVIEW Can a younger clock score translate into better health?In Episode 30, I sit down with Dr. Steve Horvath to explore epigenetic clocks, biological-age claims, and his vision for rejuvenation. We discuss why there are so many clocks, what stands between research and patient care, prevention, and why progress may come one organ at a time .👤 ABOUT THE SPEAKER Dr. Steve Horvath is Professor of Medicine and Director of Aging Biology Research at UCLA’s David Geffen School of Medicine. A geroscientist and biostatistician, he developed the influential 2013 multi-tissue DNA methylation clock.Lab profile: https://horvathaginglab.org/ 🔑 KEYWORDS Steve Horvath • Epigenetic Clocks • DNA Methylation • Biological Age • Rejuvenation • Prevention • Aging Biomarkers • Geroscience 📌 KEY TAKEAWAYS • Different aging clocks can produce different results. Horvath argues for transparent reporting across multiple clocks. • Dramatic age-reversal claims deserve scrutiny; a younger test result needs meaningful interpretation. • Horvath sees promise in clinical use, while emphasizing that routine patient care is not there yet. • Rejuvenation is connected to prevention: the aim is to preserve health before disease develops. • A realistic path may focus on individual organs rather than a single treatment for the entire body. 🎙️ THE REPROGRAM PERSPECTIVE Better measurement can sharpen the questions we ask about aging. The next challenge is connecting those measurements to outcomes that matter to people.Our focus: what changed, how reliably was it measured, and what does it mean for health and function? ⏱️ CHAPTERS 00:00 Can we measure and reverse aging? 00:51 Introducing Steve Horvath 01:40 Reinventing a research career 05:28 Why are there so many aging clocks? 07:51 Bringing clocks into clinical practice 09:16 Evaluating age-reversal claims 11:31 Rejuvenation and prevention 14:37 What does rejuvenation mean? 16:26 One organ at a time 18:36 Lifestyle, testing, and perspective...

What Long-Lived Animals Teach Us About Aging | Dr. Steve Austad

25 min

🎬 EPISODE OVERVIEW Why do some animals live so much longer than others—and what can they teach us about healthier human aging?In Episode 29 of The ReProgram, I sit down with Dr. Steve Austad to explore nature’s longevity clues, why women tend to outlive men, and what would count as convincing evidence that an intervention slows aging.We discuss aging “speedometers,” the difference between lifespan and healthspan, the case for funding geroscience, and how to evaluate biological-age claims without losing sight of enjoying life. 👤 ABOUT THE SPEAKER Dr. Steven N. Austad is a Distinguished Professor and Protective Life Endowed Chair in Healthy Aging Research at the University of Alabama at Birmingham, and Scientific Director of the American Federation for Aging Research. His research explores the comparative biology of aging, using differences among species to understand longevity and identify potential ways to preserve human health.Official profile: https://www.uab.edu/icar/about/icar-leadership/steven-n-austad-phd 🔑 KEYWORDS Longevity • Comparative Biology • Steve Austad • Healthspan • Aging Rate Indicators • Biological Age • Geroscience • Sex Differences • DunedinPACE 📌 KEY TAKEAWAYS • Long-lived animals offer clues about aging biology and potential directions for human research. • A finding in animals is a starting point; demonstrating a meaningful benefit in people requires further testing. • Measuring biological age and measuring the pace of aging are different questions. A change in a test result alone does not prove that an intervention slows aging. • Healthspan puts the focus on maintaining function and quality of life. • Evaluating longevity claims means asking what was measured, what changed, and whether the evidence supports the conclusion. 🎙️ THE REPROGRAM PERSPECTIVE Nature shows that the pace of aging varies enormously across species. Understanding the biology behind those differences could reveal ways to preserve human health.For The ReProgram, the ne...

Can We Slow Human Aging? What Would Count as Proof? | Dr. Nik Schork

43 min

🎬 EPISODE OVERVIEW The Longevity Consortium is mapping the biology of aging. We review the NIH-funded research aiming to delay chronic disease.The NIH-supported Longevity Consortium is a massive effort to understand the biology of aging to reduce risks of cancer, dementia, and frailty. We examine their five core focus areas, ranging from exceptional longevity cohorts to candidate drug screening. Dr. Nik Schork and Dr. George Murphy break down the current strategy for targeting age-related decline.This initiative represents a distinct pivot in geroscience research, moving beyond single-pathway hypotheses to look at systemic biological markers. We analyze the scope of these projects to see which are likely to yield clinical outcomes and which remain preliminary explorations. Understanding the biology of aging remains a complex challenge, but this consortium provides a structural framework for how we might eventually mitigate chronic disease. 🔑 KEYWORDS Longevity • Healthspan • Aging Biology • NIH • NIA • Longevity Consortium • Nik Schork • Centenarians • Human Cell Models • Geroscience 📌 KEY TAKEAWAYS ◆ Healthspan and lifespan are related goals, but improving a biological measurement is not the same as proving that people live longer. ◆ Exceptional longevity may reflect protective biology alongside disease-risk variants, as well as behavior and environmental exposures. ◆ The five projects connect discovery with functional testing. A genetic association still needs a biological explanation and follow-up experiments. ◆ Human cell models help isolate a signal; animal studies and human research test whether it matters in a more complex system. ◆ Public funding supports collaboration across disciplines and exploratory work that may not begin with a single commercial product. ◆ Shared aging mechanisms could offer opportunities to address multiple diseases. That is a research goal, not a claim that a proven universal treatment exists. ◆ A critical approach to evidence mat...

Can Magic Mushrooms Change How We Age? The Psilocybin Scorecard

15 min

🎬 EPISODE OVERVIEW Could the compound in magic mushrooms influence how we age? Psilocybin research is producing intriguing findings, but changing brain activity, treating depression and extending human life are very different claims.In Episode 27, Dr. George Murphy puts psilocybin through The ReProgram Scorecard. He examines experiments in human cells and aged mice, brain imaging and plasticity studies, inflammatory markers, and clinical research on depression.The episode also explores preliminary Parkinson’s and Alzheimer’s reports, why a change in a biomarker is not the same as preventing disease, and what it would take to establish a meaningful benefit for older adults.The verdict: psilocybin deserves serious investigation. The evidence discussed does not establish human life extension or dementia prevention. Its strongest clinical argument remains mental health treatment in carefully supervised settings. 🔑 KEYWORDS Psilocybin • Psilocin • Psychedelics • Longevity • Brain Plasticity • Depression • Inflammation • Cognitive Aging • ReProgram Scorecard 📌 KEY TAKEAWAYS • The longevity headline needs context. More cell divisions in a dish and improved mouse survival at a study endpoint do not demonstrate longer human life. • Brain changes are measurable. Plasticity and altered network coordination do not establish a universal neurotransmitter reset or a rejuvenated brain.• Inflammation findings vary. The marker, population and timing matter; sustained clinical benefit remains an open question. • Preliminary observations cannot establish dementia prevention. Small uncontrolled studies and an Alzheimer’s case report provide research questions, not proof of disease reversal. • Mental health benefits deserve their own assessment. Randomized evidence is encouraging, while durability, patient selection, support and adverse effects still matter. • Evidence grades are claim specific. A strong plasticity score cannot fill the evidence gap for dementia prevention or human li...

Ozempic Extended Mouse Lifespan. Does That Change the Longevity Scorecard?

12 min

ReProgram Episode 26: GLP-1 Drugs for Longevity 🎬 EPISODE OVERVIEW A drug millions of people already take extended median lifespan by approximately 12% in older female mice. Does that change the case for GLP-1 drugs as longevity therapies?In this update, Dr. George Murphy reopens The ReProgram Scorecard to examine a new Nature study of late-life semaglutide treatment. He explores the survival findings, improvements in physical and cognitive performance, and the questions that determine how broadly we should interpret the results.How long did the control animals live? How much of the benefit came from eating less? What can a study conducted in females tell us about males—and ultimately humans?The episode also examines new research connecting calorie restriction with DNA mutation accumulation, the challenge of translating mouse biology into human outcomes, and the lessons from semaglutide’s Alzheimer’s trials.The updated assessment: stronger animal evidence and more compelling questions, while the overall grade remains B+. 🔑 KEYWORDS GLP-1 • Semaglutide • Ozempic • Wegovy • Longevity • Healthy Aging • Calorie Restriction • Somatic Mutations • Healthspan • ReProgram Scorecard 📌 KEY TAKEAWAYS • The survival finding deserves attention. Median lifespan increased from 742 to 834 days when semaglutide treatment began at 20 months of age and continued throughout life. • The calorie restriction question remains open. Selected functional outcomes were compared with matched calorie restriction; lifespan was not. • A benefit in females does not establish a female-specific effect. Males were not tested. • Historical controls provide context. They cannot replace the controls studied alongside treated animals; replication remains essential. • The DNA connection is a hypothesis. New calorie restriction research raises questions about mutation accumulation, but does not establish that semaglutide reduces somatic mutations. • Human outcomes still determine the grade. Strength, mobi...

The Hidden Dangers of Aging Blood: What You Need to Know

28 min

ReProgram Episode 25: 🩸 YOUR BLOOD MAY BE AGING BEFORE YOU ARE 🧠 Episode Overview Blood aging is often overlooked, but the hematopoietic stem cells inside your bone marrow carry a decades-long history.Your blood is not just a fluid; it is a continuously renewing organ system. As the stem cells that manufacture your blood cells age, they can shift immune composition and increase susceptibility to inflammation. This process is central to understanding how systemic aging actually unfolds, moving beyond simple protein panels or biological clocks to look at the cellular machinery that sustains you.We examine the reality of clonal hematopoiesis, known as CHIP, and why it acts as a risk marker rather than a diagnosis. By separating mechanism from marketing, we clarify what parabiosis experiments and plasma exchange can—and cannot—actually achieve in human biology. Understanding blood aging helps us prioritize evidence-based outcomes over the hype of rejuvenation.Subscribe to The ReProgram for scientist-led longevity biology breakdowns, and let us know in the comments if you want a deeper look at specific plasma-related interventions.#BloodAging #LongevityScience #HealthyAging #TheReProgram 🎙️ The ReProgram Perspective Blood aging forces us to rethink a familiar assumption. The cells circulating today may be new, but their factory - the hematopoietic stem-cell system and its marrow niche - has been shaped by decades of stress, inflammation, mutation, and repair.The biology is compelling because it connects systems that are often discussed separately: immunity, cancer risk, vascular inflammation, tissue repair, and aging. CHIP is a particularly powerful example. A mutation beginning in one stem cell can eventually influence enormous numbers of immune cells and potentially affect organs far beyond the bone marrow.But risk is not destiny, and mechanism is not treatment. CHIP should not be treated as leukemia, a mouse rejuvenation experiment should not be presented as a huma...

Start Here: The ReProgram | Longevity Science Without the Hype

2 min

Welcome to The ReProgram. Longevity science moves a lot slower than longevity marketing.The ReProgram explores the biology of aging, longevity drugs, regenerative medicine, nutrition, exercise, biotechnology, and the emerging science that may help us live longer, healthier lives. Mechanism over marketing. Evidence over anecdotes. Trade-offs over hype.Understand Aging. Build Resilience. Extend Healthspan.

Can We Reprogram Aging? Epigenetics, Cell Identity & the Future of Rejuvenation | Dr. Jose Polo

29 min

🎬 EPISODE OVERVIEW Every cell in your body contains essentially the same DNA, yet a neuron behaves nothing like a skin cell. So what actually gives a cell its identity — and how permanent is that identity?In this episode, Dr. George Murphy sits down with epigenetics and cellular reprogramming expert Dr. Jose Polo to explore how cells establish identity, how that identity can be rewritten, and what reprogramming really means for aging and rejuvenation.They discuss why cellular reprogramming is not the same thing as rejuvenation, Jose’s concept of “cell elasticity,” the danger of pushing a cell so far that it loses its identity, and the possibility of using targeted cell conversion as regenerative medicine. 👤 ABOUT THE GUEST Dr. Jose M. Polo is Director of the Adelaide Centre for Epigenetics in Australia. His research focuses on the transcriptional and epigenetic mechanisms that govern cell identity, pluripotency, cellular reprogramming, early development, and cancer. His laboratory has helped define the molecular sequence of somatic-cell reprogramming, developed strategies for direct cell-fate conversion, and pioneered human iBlastoid models of early embryonic development.Official profile: https://researchers.adelaide.edu.au/p... 🔑 KEYWORDS Epigenetics • Cellular Reprogramming • Cell Identity • Rejuvenation • Partial Reprogramming • Yamanaka Factors • Induced Pluripotent Stem Cells • Cell Elasticity • Epigenetic Clocks • Regenerative Medicine • iBlastoids • Human Embryo Models • Longevity • Aging 📌 KEY TAKEAWAYS • Cell identity is regulatory, not genetic. The same genome can produce radically different cell states depending on which programs are active. • Reprogramming is not the same as rejuvenation. Resetting cellular state may erase age-associated features, but that does not automatically mean restored function. • “Cell elasticity” may define the safe window for partial reprogramming. A cell can move away from its identity and return — until it crosses a point...

Creatine for Longevity? What the Science Actually Shows

20 min

🧠 EPISODE OVERVIEW Creatine is cheap, widely available, and backed by an unusually large body of human research. But its biology extends well beyond the gym. The creatine–phosphocreatine system helps cells rapidly regenerate ATP when energy demand rises—in both muscle and brain. In this episode, we examine the evidence for creatine and muscle preservation, cognition and brain resilience, kidney safety, dosing, and emerging high-dose brain protocols. And most importantly: does any of this make creatine a true longevity supplement? Creatine goes through The ReProgram Scorecard. Mechanism over marketing. Evidence over anecdotes. Trade-offs over hype. 🔑 KEYWORDS Creatine • Creatine Monohydrate • Longevity • Healthspan • Muscle • Strength • Resistance Training • Brain Health • Cognition • ATP • Phosphocreatine • Kidney Health • Healthy Aging 🧠 KEY TAKEAWAYS Energy: Creatine helps buffer cellular energy by supporting rapid ATP regeneration. Muscle: The strongest evidence is for strength and performance. Combined with resistance training, creatine can improve strength and augment gains in lean tissue. Brain: Cognitive evidence is promising but less established. Benefits may be most relevant when the brain is under energetic stress. Alzheimer’s: Creatine is not proven to prevent or treat Alzheimer’s disease. Higher-dose brain protocols remain experimental. Kidneys: Safety data in healthy individuals are reassuring. Creatine can raise serum creatinine without necessarily indicating kidney damage. Dose: For most people, 3–5 g/day of creatine monohydrate is the conventional evidence-based approach. Loading is optional. Longevity: Healthspan evidence is not lifespan evidence. There is currently no randomized human evidence that creatine extends human lifespan. 🎙️ THE REPROGRAM PERSPECTIVE Creatine combines compelling biology, strong human evidence for specific outcomes, low cost, and reassuring safety—without proving that it slows human aging. Sometimes the most interesting...

Can We Make Our Pets Live Longer? The Science of Pet Longevity

37 min

🐾 EPISODE OVERVIEW This episode asks a deceptively simple question: Can we actually help our dogs and cats live longer, healthier lives?We explore why companion animals are unusually powerful models of aging, why “one dog year equals seven human years” is biologically wrong, what the Dog Aging Project is revealing, what pet owners can reasonably do today, and where emerging interventions like rapamycin, canine longevity drugs, AIM therapy, and gene therapy fit into the evidence. 🔑 KEYWORDS Pet longevity, dog aging, cat aging, healthspan, Dog Aging Project, rapamycin, TRIAD Trial, Loyal, feline kidney disease, AIM/CD5L, gene therapy, pet nutrition, body condition, muscle preservation, geroscience, comparative aging, healthy aging, veterinary medicine 💡 KEY TAKEAWAYS • Dogs and cats may be powerful real-world models of aging because they share our homes, environments, behaviors, and many naturally occurring diseases. • Dog years are not human years. Aging rates change throughout life and vary dramatically by breed and body size. • For most pets, the strongest longevity strategies today remain surprisingly conventional: appropriate body composition, good nutrition, movement, muscle preservation, dental care, pain management, preventive medicine, and early disease detection. • Rapamycin, dedicated canine longevity drugs, AIM therapy, and gene therapies are scientifically exciting—but they remain at different stages of experimental validation. • Healthspan matters more than lifespan at any cost. More time only matters if we preserve the experiences that make an animal recognizably itself. 🎙️ THE REPROGRAM PERSPECTIVE Pet longevity is a perfect example of why we need to separate mechanistic plausibility from meaningful outcomes.A supplement that changes a biomarker is not necessarily extending healthspan. An intervention that treats one age-related disease is not necessarily slowing aging throughout the entire organism. And an exciting mouse study is not a reason to st...

Can We Reprogram Aging Through Mitochondria? | Dr. Stefan Isaac

33 min

🧠 Episode Overview Mitochondria are known as the powerhouses of the cell—but energy production is only part of their story.In this episode of The ReProgram, Dr. George Murphy speaks with mitochondrial biologist Dr. Stefan Isaac about mitochondrial DNA, heteroplasmy, stress signaling, mitophagy, genome editing, and the possibility of transferring healthy mitochondria into damaged or aging cells.They also explore a central longevity paradox: more mitochondrial activity may not always be better. Long-lived organisms and centenarian-derived cells may preserve health through lower baseline activity, greater efficiency, and a stronger capacity to respond to stress.Could we replace aging mitochondria, repair mutant mitochondrial DNA, or generate rejuvenated mitochondria from reprogrammed cells? And would a young mitochondrion remain healthy inside an old cellular environment? 🔑 KeywordsStefan Isaac, mitochondria, mitochondrial aging, mitochondrial DNA, heteroplasmy, mitophagy, mitochondrial transfer, mitochondrial transplantation, genome editing, cellular reprogramming, centenarians, longevity, healthspan, ReProgram Podcast 🧠 Takeaways • Mitochondria regulate metabolism, stress signaling, and cell fate—not just energy production. • More mitochondrial activity is not necessarily better; longevity may depend on efficiency, adaptability, and recovery. • Exercise remains the strongest evidence-based strategy for supporting mitochondrial function. • Transplanted mitochondria remain dependent on the recipient cell’s nuclear genome and cellular environment. • Genome editing and selective removal of mutant mitochondrial DNA may transform future mitochondrial medicine. 🎙️ The ReProgram Perspective Resilience over raw output. Function over biomarkers. Mechanism over marketing.The longevity industry often assumes that more energy, more mitochondrial biogenesis, and more metabolic activity must be better. This episode challenges that assumption.A mitochondrion should not be judged...

The ReProgram Scorecard: Metformin and Longevity

15 min

🧠 Episode Overview Metformin is inexpensive, widely prescribed, and supported by decades of clinical experience. It is also one of the most frequently discussed drugs in longevity medicine.But does metformin actually slow human aging?In this episode, Dr. George Murphy puts metformin through The ReProgram Scorecard, examining its biological mechanisms, human evidence, safety, accessibility, and likely value for people with—and without—metabolic disease.The central distinction is context. Metformin can delay diabetes in people at elevated metabolic risk, but evidence that it extends lifespan or broadly prevents age-related disease in metabolically healthy adults remains limited. Final ReProgram Grade: B− For healthy-adult longevity use: C+ 🔑 Keywords Metformin, metformin and longevity, biological aging, healthspan, diabetes prevention, insulin resistance, prediabetes, anti-aging drugs, longevity medicine, ReProgram Scorecard, Dr. George Murphy 🧠 Key Takeaways • Metformin is an established metabolic drug, not a proven anti-aging medication. • Its mechanisms intersect with energy sensing, glucose regulation, inflammation, mitochondrial biology, AMPK, and mTOR. • The strongest benefits are seen in people with diabetes, prediabetes, insulin resistance, or elevated metabolic risk. • Evidence that healthy, insulin-sensitive adults benefit from taking metformin for longevity is weak. • Long-term follow-up found that metformin prevented diabetes but did not significantly reduce all-cause, cardiovascular, or cancer mortality. • The key question is not whether metformin affects aging-related pathways. It is whether it improves meaningful outcomes in the right population. 🎙️ The ReProgram Perspective Mechanism over marketing.Evidence over anecdotes.Trade-offs over hype.Metformin deserves respect as a safe, inexpensive, and valuable metabolic medicine.But correcting abnormal metabolism is not necessarily the same as slowing aging in someone whose metabolism is already healthy....

Dr. Raghav Sehgal: Can We Measure How Fast You Are Aging?

27 min

🧠 Episode Overview What if your age on paper is not the number that matters most?In this episode of The ReProgram, Dr. George Murphy sits down with Dr. Raghav Sehgal at the Gordon Research Conference Systems Aging Meeting in Maine.Dr. Sehgal discusses his work analyzing dozens of putative longevity interventions across epigenetic clocks, why DNA methylation data are uniquely useful for cross-study harmonization, and why some interventions may move aging biomarkers only in specific biological contexts.The central message: aging clocks are not magic answers, but they may become powerful instruments for separating longevity science from longevity marketing. 🔑 Keywords Raghav Sehgal, biological age, chronological age, aging clocks, epigenetic clocks, biomarkers of aging, longevity interventions, geroscience, AI and aging, artificial intelligence, rapamycin, metformin, hronic inflammation, lifestyle interventions, exercise, diet, supplements, follistatin gene therapy, clinical translation, precision longevity, ReProgram Podcast, Dr. George Murphy 🧠 Takeaways • Chronological age tells us how long we have been alive; biological age attempts to measure how fast health risk and physiological decline are progressing. • If aging cannot be quantified, it becomes difficult to test whether an intervention is actually modifying aging biology. • Epigenetic clocks are especially useful for large cross-study analyses because DNA methylation platforms are relatively standardized compared with many other omics technologies. • Dr. Sehgal describes a major harmonization effort across clinical trials and observational studies to ask which interventions move aging biomarkers. • Some surprising signals came from anti-retroviral therapy and inflammation-targeting drugs, raising questions about retrotransposons, immune activation, and chronic inflammation in aging. • Context matters: an intervention may shift aging biomarkers in one group, disease state, tissue, or organ system but not ano...

Dr. Mimi Shirasu-Hiza: Can Meal Timing Slow Aging?

13 min

🧠 Episode Overview What if aging is shaped not only by what you eat, how much you exercise, or which genes you inherit — but also by when your body does things each day?In this episode of The ReProgram, Dr. George Murphy sits down with Dr. Mimi Shirasu-Hiza at the Gordon Research Conference Systems Aging Meeting in Maine.Dr. Shirasu-Hiza is a Professor of Genetics and Development at Columbia University and an international expert in circadian gene regulation, aging, and health.This conversation explores circadian rhythms as daily, approximately 24-hour oscillations in gene expression, tissue function, and behavior — and why disruption of those rhythms through shift work, jet lag, irregular sleep, or mistimed eating may affect metabolism, cardiovascular risk, obesity, cancer risk, and aging biology.A major focus is time-restricted eating: not simply eating less, but aligning eating and fasting with the body’s active and resting phases. Dr. Shirasu-Hiza discusses work in fruit flies showing that time-restricted eating can extend lifespan and preserve youthful oscillations in genes involved in metabolism, protein translation, immune defense, stress response, and other core biological programs. 🔑 Keywords Circadian rhythms, circadian clock, biological rhythms, time-restricted eating, intermittent fasting, caloric restriction, meal timing, fasting window, overnight fasting, metabolism, cardiovascular disease, obesity, cancer risk, aging biology, longevity science, geroscience, exercise, healthspan, resilience, ReProgram Podcast, Dr. George Murphy 🧠 Takeaways • Circadian rhythms are daily, approximately 24-hour oscillations in gene expression, tissue function, and behavior. • The circadian clock is not just about sleep; it helps coordinate transcription, metabolism, feeding, fasting, activity, tissue function, and recovery. • Circadian disruption is associated with cardiometabolic disease, obesity, and cancer risk, especially in shift workers, frequent travelers, and o...

Dr. Rich Miller: “There Are No Biomarkers of Aging”

31 min

🧠 Episode Overview What if “biological age” as a single number is the wrong way to think about aging?In this episode of The ReProgram, Dr. George Murphy sits down with Dr. Rich Miller at the Gordon Research Conference Systems Aging Meeting in Maine.Dr. Miller is a Professor of Pathology at the University of Michigan and one of the leaders of the Interventions Testing Program, the gold standard for testing longevity interventions in genetically diverse mice.This conversation challenges some of the biggest assumptions in longevity science: biomarkers of aging, cellular senescence, the search for one cause of aging, and the idea that mouse lifespan results automatically translate into human recommendations.The central message:Aging is not one pathway, one biomarker, or one number.The real question is not simply what causes aging.The real question is what can postpone many forms of age-related decline at the same time. 🔑 Keywords Richard Miller, Interventions Testing Program, ITP, aging biology, longevity science, geroscience, biological age, biomarkers of aging, aging-rate indicators, anti-aging drugs, geroprotectors, rapamycin, acarbose, ergothioneine 🧠 Takeaways • Aging should not be reduced to one cause, one pathway, one biomarker, or one biological age number. • Rich Miller argues that the key question is not what causes aging, but what postpones many forms of age-related damage at once. • Lifespan is useful because it is definitive, but a true anti-aging drug should also delay multiple forms of functional decline. • Most proposed longevity interventions fail when tested rigorously. • Biomarkers of aging and aging-rate indicators are not the same thing. • A biomarker may change with age. An aging-rate indicator should tell us whether aging is moving faster or slower. • “Biological age” as a single number may hide important differences across tissues, systems, and disease risks. • Ergothioneine is intriguing in slow-aging mice, but it is not yet clear whether it...

GLP-1 Agonists and Longevity: The First ReProgram Scorecard

25 min

🧠 Episode Overview Are GLP-1 agonists longevity drugs?Not weight loss drugs.Not cosmetic drugs.Not simply appetite drugs.In this episode of The ReProgram, Dr. George Murphy launches a new recurring format: The ReProgram Scorecard — a science-first framework for grading popular longevity interventions through the same lens every time:Mechanistic plausibility.Human evidence.Magnitude of likely benefit.Safety and downside risk.Who may benefit most.Who should be cautious.Cost and accessibility.Longevity hype risk.And the final ReProgram grade. 🔑 Keywords GLP-1 agonists, GLP-1 and longevity, semaglutide, Ozempic, tirzepatide, metabolic health, healthspan, aging biology, inflammation, brain aging, cognitive decline, neuroinflammation, neuronal resilience, longevity medicine, geroscience, The ReProgram Podcast, Dr. George Murphy. 🧠 Takeaways • GLP-1 agonists should not be understood only as weight-loss drugs. • GLP-1 agonists are not yet proven to slow biological aging, extend lifespan, reverse aging clocks, prevent frailty, or broadly preserve function across all older adults. • The magnitude of likely benefit is highly context-dependent. People with obesity, insulin resistance, type 2 diabetes, cardiovascular risk, fatty liver disease, metabolic syndrome, or inflammation linked to metabolic dysfunction may benefit most. • For metabolically healthy people using GLP-1 agonists purely as longevity hacks, the benefit is much less clear. • Safety matters. These are real drugs with real side effects, and they should not be treated as casual wellness supplements.• Lean mass preservation is critical. Weight loss without attention to resistance training, protein intake, and muscle maintenance may undermine long-term resilience, especially in older adults. 🎙️ The ReProgram Perspective The ReProgram lens is clear:Mechanism over marketing.Evidence over anecdotes.Trade-offs over hype.GLP-1 agonists are not magic. They are not proven anti-aging drugs. And they should not be market...

Can AI Decode Human Aging?

21 min

ReProgram Episode 14 AI and Longevity: Hype, Hope, and the Biology of Aging 🧠 Episode Overview What if your doctor could look at your bloodwork, medical history, genome, proteins, metabolites, microbiome, and health trajectory - and tell you more than whether you are sick today?Can artificial intelligence decode human aging?AI will not magically cure aging. It will not replace biology. And it will not tell us exactly how to live forever.But it may help us do something incredibly important:See patterns in human aging that are too complex for the human mind to detect alone.In this episode of The ReProgram, Dr. George Murphy explores the real promise of AI in longevity science — and where the hype goes wrong.Aging is not one gene, one pathway, one biomarker, or one supplement. Aging is a moving, interacting network across time.That is why AI matters.But prediction is not understanding.A biomarker is not an outcome.And an AI-generated recommendation is not automatically personalized medicine.The future is not AI instead of biology.It is AI plus biology. 🧠 Takeaways • AI will not magically cure aging, but it may become one of the most powerful tools for organizing biological complexity. • Aging is not a single pathway, gene, biomarker, or intervention. It is a dynamic network that changes over time. • The most useful question is not simply whether AI can predict aging, but whether AI can help us understand, measure, and eventually preserve resilience. • AI can identify patterns across massive datasets, but pattern recognition is not the same as biological truth. • Prediction is not understanding. An AI model may predict risk without explaining the mechanism behind that risk. • Bad data plus powerful AI does not create truth. It creates confident noise. • AI-generated health recommendations are not automatically personalized medicine; they may be personalized guesses delivered with confidence. • The future of longevity science is not AI instead of biology. It is AI plus...

NAD and Aging: Did We Get the Story Wrong

22 min

ReProgram Episode 14 The NAD Myth? What the New Human Data Really Say🧠 Episode Overview In this episode of The ReProgram, Dr. George Murphy takes a critical but balanced look at one of the most popular ideas in the longevity space:That NAD levels decline with age — and that boosting NAD may help slow aging.But new human data challenge one of the most common assumptions behind the NAD story:Whole-blood NAD levels may not decline with age.This episode explores what that finding means — and what it does not mean.The central takeaway:NAD is not dead.But the simplistic NAD longevity story needs a reset. 🔑 Keywords NAD, NAD+, aging, longevity, NR, NMN, NAD boosters, nicotinamide riboside, nicotinamide mononucleotide, mitochondrial function, DNA repair, sirtuins, PARPs, CD38, cellular metabolism, biological aging, healthspan, resilience, recovery capacity, inflammation, stress response, biomarker, whole-blood NAD, NAD decline, NAD supplements, NAD IV therapy, metabolism, cellular stress, anti-aging supplements, longevity science, The ReProgram Podcast 🧠 Takeaways • NAD is essential biology, but it should not be treated as a magic anti-aging molecule. • New human data challenge the idea that whole-blood NAD levels universally decline with age. • Raising blood NAD is not the same thing as proving that aging has slowed. • NAD biology is likely tissue-specific, disease-specific, stress-specific, and context-dependent. • Blood NAD is not necessarily a reliable window into NAD metabolism in muscle, brain, liver, immune cells, or other tissues. • NAD boosters like NR and NMN can raise NAD-related metabolites, but that does not automatically mean they improve healthspan or longevity. • The most honest current framing is that NAD boosters are biologically plausible, biomarker-active, and clinically unproven as general longevity therapies. • NAD may be more relevant in specific contexts of stress, disease, frailty, metabolic dysfunction, or impaired recovery than as a universal...

Measuring and Modifying Biological Age: What the Science Actually Shows

44 min

ReProgram Episode 13 🧠 Episode Overview What does it actually mean to measure your biological age—and can it be changed? In this episode of The ReProgram, Dr. George Murphy sits down with Dr. Jesse Poganik, a leading scientist in the field of biological aging clocks and biomarkers of aging. Together, they unpack the science behind biological age—how it’s measured, what it reflects, and whether it represents a causal driver of aging or simply a readout of deeper biological processes. This conversation goes beyond the hype. It explores the emerging tools used to quantify aging, the limitations of current approaches, and what it will take to translate these measurements into meaningful clinical interventions. From organ transplantation to immune system signaling, Dr. Poganik shares how real-world biological systems are helping decode the mechanisms that shape how we age. 🔑 Keywords biological age, epigenetic clocks, aging biomarkers, DNA methylation, longevity science, healthspan, resilience, systems biology, immune aging, biomarkers of aging, translational medicine, aging mechanisms, clinical biomarkers, longevity interventions 🔬 What You’ll Learn • What “biological age” actually measures—and what it doesn’t • How epigenetic clocks are built and why they’ve gained traction • The difference between correlation and causation in aging biomarkers • Why systemic signals (like blood and immune factors) may regulate aging • How organ transplantation provides a natural experiment in aging biology • The biggest challenges in bringing biological age testing into the clinic • What standardization efforts (like the Biomarkers of Aging Consortium) aim to solve • Whether modifying biological age is currently possible—and what’s coming next 🎙️ The ReProgram Perspective Biological age is not just a number to optimize.It is a signal—one that reflects deeper biological processes we are only beginning to understand.The challenge is not simply to measure aging more precisely....

The Biology of Recovery: Why Adaptation Fails in Modern Life

20 min

ReProgram Episode 12 Most people think they need to do more.Train harder. Push further. Add more stimulus.But what if the real problem isn’t effort…What if your body can no longer recover from what you’re already doing?In this episode of The ReProgram, Dr. George Murphy reframes aging, performance, and longevity through a different lens:Recovery capacity.Rather than viewing aging as simple decline, this episode explores a more fundamental idea:that aging is the progressive loss of dynamic resilience—your ability to recover from stress.Because adaptation doesn’t come from what you do.It comes from what your body can recover from.If you’re training hard but not progressing…If you’re doing more but getting less back…If fatigue is accumulating instead of resolving…The issue may not be effort.It may be recovery. This episode breaks down: • What recovery actually is (and why it’s not passive) • Why modern life disrupts recovery at a systems level • The biological relationship between stress, adaptation, and repair • Why increasing effort can sometimes accelerate decline • How to recognize when recovery—not stimulus—is the limiting factor • A new framework for thinking about aging, resilience, and long-term function This is not a conversation about doing less.It’s a conversation about aligning what you ask of your body with what it can actually recover from.Because ultimately, resilience is not defined by how much stress you can endure—It’s defined by how well you can recover. 🔑 Keywords recovery, resilience, aging, longevity, adaptation, stress, recovery capacity, overtraining, fatigue, burnout, performance plateau, healthspan, systems biology, metabolic health, sleep, training, exercise physiology, nervous system, hormesis, modern stress, biological resilience 🧠 Takeaways • Recovery is not passive—it is an active biological process that determines whether stress leads to adaptation or breakdown. • The body does not adapt to what we do; it adapts to what it can rec...

Muscle, Strength and The Biology of Staying Capable

24 min

In this episode of The ReProgram, Dr. George Murphy reframes skeletal muscle as far more than tissue for movement or aesthetics.Muscle is one of the body’s most powerful regulators of metabolic stability, resilience, recovery, and long-term functional independence.This conversation explores why the loss of muscle with age is not simply about weakness—it is a systems-level shift that affects glucose regulation, balance, neuromuscular coordination, recovery from stress, and ultimately how aging is experienced.Dr. Murphy breaks down the biology of sarcopenia, the profound role of resistance training across the lifespan, and why it is never too late to restore meaningful strength and function.The episode also challenges a common myth in aging:that we should reduce challenge as we get older.Instead, the real goal is intelligent, appropriately scaled resistance that preserves the biological signals required for adaptation.This is not a conversation about physique.It is a conversation about remaining capable.About preserving the systems that allow us to move through the world with confidence, recover from disruption, and maintain independence for as long as biology allows. 🔑Keywords muscle, skeletal muscle, strength, longevity, resistance training, sarcopenia, healthy aging, healthspan, neuromuscular aging, frailty, metabolism, glucose regulation, muscle loss, functional aging, independence, resilience, exercise science, late-life training, muscle physiology, healthy lifespan 🧠 Takeaways • Skeletal muscle is not cosmetic tissue—it is biological infrastructure for metabolism, recovery, and resilience. • Aging is experienced through loss of function, and muscle is one of the most modifiable systems that shapes that trajectory. • Resistance training remains effective across the lifespan, even when initiated later in life. • “Heavy” is relative to current capacity—the goal is intelligent challenge, not maximal load. • Strength reflects integrated systems biology, including m...

Peptides for Longevity: What No One Tells You About Anti-Aging

27 min

In this episode—Part 3 of the Peptides 101 series—we move beyond healing and performance to examine one of the most compelling and misunderstood frontiers in modern medicine: longevity and anti-aging peptides.But this is where the conversation changes.Because using peptides to recover from injury is fundamentally different from using them to modify the trajectory of aging itself.In this episode, we break down the biology behind commonly discussed longevity peptides—including Epitalon, MOTS-c, and Thymosin Alpha-1—through the lens of signaling, systems biology, and long-term risk.We explore critical pathways like mTOR, telomere dynamics, mitochondrial signaling, and immune regulation, and examine the central tension that defines aging biology: 👉 The same signals that promote growth and repair early in life may accelerate disease later on.This episode is not about hype.It’s about mechanism, trade-offs, and the reality that biology does not offer intervention without consequence. 🔑Keywords peptides, anti-aging, longevity, mTOR, telomeres, mitochondria, cancer risk, regeneration, immune signaling, growth hormone, epitalon, MOTS-c, thymosin alpha-1, signaling, science, clinical trials, regenerative medicine, aging biology, healthspan 🧠 Takeaways • Peptides are not supplements—they are biological signals that influence complex systems. • Longevity interventions aim to alter trajectory, not just restore baseline.• Growth signaling pathways (GH, IGF-1, mTOR) create a fundamental trade-off between repair and long-term risk. • Aging is not driven by a single pathway—it reflects interconnected biological systems under constraint. Epitalon (Telomere Biology) • Proposed to activate telomerase and influence cellular aging. • Telomerase is tightly regulated for a reason—uncontrolled activation is a hallmark of cancer biology. • Long-term human outcome data remains limited. MOTS-c (Mitochondrial Signaling) • A mitochondrial-derived peptide involved in metabolic regulation and st...

The Secret Lives of Super Agers: What 100-Year-Olds Teach Us About Aging

25 min

ReProgram Episode 10 In this insightful interview, Dr. Stacy Andersen, a behavioral neuroscientist and expert in aging research, shares her journey into the study of exceptional longevity, the characteristics of centenarians, and the biological and lifestyle factors that contribute to healthy aging. Discover how resilience to disease, genetic protective factors, and lifestyle choices intertwine to shape the future of longevity. Keywords longevity, centenarians, healthy aging, resilience, genetics, lifestyle, Alzheimer's, cognitive health, aging research Takeaways Resilience is key to aging well, focusing on quality of life over mere longevity. Diverse paths, including genetics and lifestyle, lead to exceptional aging. Longevity results from complex interactions between genes and behaviors. Cognitive resilience can stem from managing or avoiding pathologies. A sense of purpose significantly contributes to lifespan and health span. Centenarians exemplify how lifestyle, genetics, and purpose optimize healthspan.Office Artifact On the desk: Godzilla, MechaGodzilla and Ultraman, Bandai Toys, Tokyo, Japan, 2018 Chapters 00:00 Rethinking Aging: A New Perspective 02:21 Dr. Andersen’s Journey Into Longevity Science 04:32 Defining Exceptional Longevity 05:51 Not All Centenarians Are Created Equal 08:37 Characterizing Centenarians 10:51 Cognitive Super Agers 13:48 Resilience and Avoiding Aging-Related Disease 18:08 Becoming Centenarian-like 22:01 Purpose = Longevity 22:56 Aging Is Not A Single Trajectory Resources The New England Centenarian Study - https://www.bumc.bu.edu/centenarian/ Jim Fries' Compression of Morbidity Hypothesis - https://en.wikipedia.org/wiki/Compression_of_morbidity Dr. Stacy Andersen's Research at Boston University - https://profiles.bu.edu/Stacy.Andersen

Can We Measure Aging? The Truth About Biological Aging Clocks

28 min

ReProgram Episode 9 In this episode of the Reprogram podcast, Dr. George Murphy interviews Dr. Nicholas Skivir, an expert in biological aging clocks. They discuss the differences between biological and chronological age, the complexities of measuring aging, and the construction and application of biological aging clocks. The conversation delves into factors influencing biological age, the role of disease in aging, and the potential future applications of biological aging clocks in clinical practice. The episode emphasizes the importance of understanding biological age as a metric for health and longevity. Keywords biological aging, chronological age, aging clocks, epigenetic clocks, healthspan, longevity, regenerative medicine, aging research, biological metrics, disease modeling Takeaways Biological age is a more physiological measure than chronological age.Aging clocks can predict health outcomes and morbidity.The construction of biological aging clocks involves various omics data.Epigenetic clocks are preferred due to their stability and reproducibility.Biological age can be influenced by lifestyle factors like diet and exercise.Disease can act as a driver of biological age in models.Future clinical practice may incorporate biological aging metrics.Understanding biological age can inform personalized medicine.The field of aging research is rapidly evolving with new models.Interpretability of biological aging clocks remains a challenge.Office Artifact On the desk: Bow and Quiver with Arrows; The sap of the Antiaris toxicaria tree is used to make arrow poison, historically used for hunting and warfare, Indonesia 2017 Chapters 00:00 Introduction to Biological Aging Clocks 03:21 Understanding Biological vs. Chronological Age 05:33 The Complexity of Measuring Aging 06:35 Construction of Biological Aging Clocks 10:51 Factors Influencing Biological Age 14:57 Cellular Rejuvenation via Reprogramming 16:47 Disease as a Driver of Biological Age 17:51 What Clocks Do Well......

Peptides for Healing & Performance: BPC-157, TB-500 & Growth Hormone Explained

28 min

In this episode of Peptides 101, Dr. George Murphy delves into the application of peptide science in real-world scenarios, focusing on the distinction between peptides as signals versus supplements. He discusses the compelling nature of healing peptides, particularly BPC 157 and TB 500, and the importance of understanding the scientific evidence behind their use. The conversation emphasizes the gap between anecdotal claims and clinical data, urging listeners to approach peptide use with caution and humility. The episode concludes with a preview of future discussions on peptides related to aging and longevity. Keywordspeptides, healing, recovery, BPC 157, TB 500, growth hormone, regenerative medicine, healthspan, geroprotectors, longevity Takeaways Peptides are signals that instruct cells, not supplements that provide direct benefits.Healing peptides are appealing due to the urgency created by injuries and chronic pain. BPC 157 is often marketed with exaggerated claims, leading to misconceptions about its efficacy.Human clinical data on BPC 157 is limited, with no large trials supporting its healing claims.TB 500 is framed as an amplifier of healing, but lacks substantial human trial evidence.Growth hormone signaling peptides are seen as safer alternatives but also require caution.The biological mechanisms of peptides are often plausible, but human outcome data is frequently lacking.Anecdotal evidence does not equate to scientific proof of efficacy.Office Artifact On the desk: Mongol archer on horseback, Ulaanbaatar, Mongolia 2018 Chapters 00:00:00 Understanding Peptides: Signals, Not Supplements 00:03:06 The Emotional Appeal of Healing Peptides 00:04:09 BPC 157: The Wolverine Metaphor and Its Implications 00:06:57 The Reality of BPC 157: Signal Modulation vs. Tissue Regeneration 00:09:12 The Absence of Human Clinical Data on BPC 157 00:11:04 Exploring TB500: The Amplifier of Healing 00:13:50 Risks and Negative Outcomes of Peptide Use 00:15:19 Understanding TB500: He...

Peptides 101: The Biology Behind the Hype

18 min

The ReProgram Episode 8A: The first in a 3 part series In this episode, Dr. George Murphy delves into the world of peptides, exploring their scientific basis, the misconceptions surrounding them, and the importance of understanding their structure and function. He discusses the differences between natural and synthetic peptides, the manufacturing process, and the potential risks associated with peptide use. The conversation aims to provide clarity in a landscape filled with hype and misinformation, setting the stage for future discussions on specific peptides and their claims. Keywords peptides, science, health, longevity, biochemistry, molecular biology, regenerative medicine, risks, benefits, healthspan, geroprotectors, longevity Takeaways Peptides are being marketed as shortcuts to health benefits.Understanding peptides requires knowledge of their structure and function.The same term 'peptides' can refer to both regulated medicine and unregulated products.Peptides can have unintended effects if not properly understood.Natural peptides are often modified for better efficacy, which changes their behavior.Manufacturing quality is crucial for peptide effectiveness and safety.Contaminated or poorly manufactured peptides can pose serious health risks.Social media often emphasizes benefits without discussing potential failures.Science focuses on understanding risks and failure modes in peptide use.Future episodes will explore specific peptides and their claims.Office Artifact On the desk: Polynesian Tiki, a representation of a half-human, half-god figure symbolizing protection, strength, and ancestral connection, Morea, French Polynesia 2021 Chapters 00:00:00 Introduction to Peptides: The Current Landscape 00:01:56 Understanding Peptides: Science vs. Hype 00:03:46 The Structure and Function of Peptides 00:06:58 Natural vs. Designed Peptides 00:10:06 Where Off Target Effects Enter the Picture 00:11:21 The Production and Quality of Peptides 00:15:20 Risks and Negative O...

Ozempic Isn’t a Weight-Loss Drug | The Real Science of GLP-1s

16 min

The ReProgram Episode 7 In this episode of the Reprogram Podcast, Dr. George Murphy explores the rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, discussing their mechanisms, effects on metabolism, and implications for aging and healthspan. He emphasizes that these drugs are not merely weight loss solutions but agents that act on multiple organs to reprogram how the body regulates energy and hunger. The conversation also addresses the potential benefits and drawbacks of these drugs, including their impact on muscle mass and overall health. Keywords GLP-1 drugs, Ozempic, Wegovy, Mounjaro, weight loss, metabolic health, aging, healthspan, geroprotectors, longevity Takeaways Almost everyone knows someone on a GLP-1 drug.These drugs feel like a miracle for some, unsettling for others.GLP-1 drugs are not just weight loss drugs; they reprogram energy regulation.The rapid adoption of GLP-1 drugs reveals widespread metabolic dysfunction.GLP-1 drugs improve blood sugar control and reduce cardiovascular events.Weight loss is a visible effect, but metabolic changes are deeper.GLP-1 drugs may act as geroprotectors by improving healthspan.Muscle loss is a significant concern with GLP-1 drugs.Combining pharmacology with resistance training may yield the best outcomes.The future of aging involves knowing when to use drugs versus lifestyle changes.Office Artifact On the desk: Commemorative souvenirs from the Sumo World Championships, Ohama Sumo Stadium, Sakai City, Osaka, Japan 2019 Chapters 00:00:00 Introduction to GLP-1 Drugs and Their Impact 00:02:13 How Widespread is the Use of GLP-1 Drugs? 00:03:35 What Are GLP-1 Drugs and How Do They Work? 00:06:43 Weight Loss vs. Metabolic Reprogramming 00:09:23 GLP-1 Drugs as Potential Geroprotectors 00:12:31 Drawbacks and Considerations of Taking GLP-1 Drugs 00:14:55 GLP-1 Drugs, Metabolism, and the Future of Aging

Inside the Aging Brain: Dementia, Resilience, and What We Can Do!

37 min

Episode 6 This episode of the ReProgram podcast, featuring Dr. Benjamin Wolozin, delves into the complexities of neurodegenerative diseases and brain aging, with a focus on Alzheimer's. The discussion covers the diversity of these diseases, diagnostic challenges, and the future of research. The conversation is enriched with personal stories and expert insights, providing a comprehensive understanding of the topic. Keywords memory, aging, dementia, Alzheimer’s, cognitive health, sleep, phospho-tau, biomarkers, cognitive decline, health tests, longevity Takeaways Understanding the diversity of neurodegenerative diseases is crucial.Early diagnosis of Alzheimer's remains a significant challenge.Research is advancing, but there's still a long way to go.Personal stories provide valuable insights into the impact of these diseases.The role of genetics in neurodegeneration is complex and multifaceted.Public awareness and education are key to addressing these diseases.Innovative research methods are being developed to tackle Alzheimer's.Collaboration among scientists is essential for progress.Funding and grant writing are critical components of research.There is hope for future breakthroughs in treatment and diagnosis.Office Artifact On the desk: The Vietnamese conical hat called Nón lá (pronounced "non lah"), meaning "leaf hat," made from palm leaves and bamboo, serving as a cultural symbol and protection from sun/rain. Hanoi, Vietnam Chapters 00:00:59 Dr. Benjamin Wolozin’s Journey into Neuroscience 00:04:19 What is Alzheimer’s Disease and How Do We Define It? 00:09:35 Cognitive Decline and Aging 00:11:07 Heart Health is Brain Health 00:12:01 Challenges in Alzheimer’s Drug Development 00:16:14 The Role of Biomarkers in Diagnosis 00:19:54 Genetics vs. Environment in Neurodegenerative Disease 00:22:22 Know Your Genetics By Observing Your Family! 00:25:02 Targeting Aging to Prevent Neurodegeneration 00:29:04 Grant Funding and the Future of Research 00:33:52 Optimism for Futur...

The Rise of Longevity Clinics

29 min

Episode 5 In this episode of the Reprogram podcast, Dr. George Murphy explores the burgeoning world of longevity clinics, particularly in Thailand, where anti-aging treatments have become mainstream. He delves into the science behind stem cell therapies, the rise of IV drip bars, and the booming aesthetic dermatology industry. The conversation highlights the accessibility and affordability of these treatments in Thailand, while also addressing the potential pitfalls and the importance of navigating this landscape with caution. Ultimately, the episode emphasizes the need for a balanced understanding of longevity science and the commercial industry surrounding it, advocating for patient safety and informed decision-making. Keywords longevity, anti-aging, Thailand, stem cells, IV drips, aesthetic treatments, wellness tourism, regenerative medicine, aging biology, health Takeaways Longevity clinics are becoming mainstream, especially in Thailand.Thailand is strategically positioned as a global medical wellness destination.Stem cell therapies have legitimate applications but are often misrepresented.IV drip bars offer hydration but may not provide significant health benefits.Laser treatments can produce meaningful results when performed by skilled practitioners.The Brotox movement reflects changing attitudes towards men's aesthetics.Thailand's longevity industry is characterized by accessibility and affordability.Consumers must be cautious of over-promising marketing in the longevity space.Questions about treatment safety and efficacy are crucial for informed decisions.Scientific breakthroughs in aging are emerging, but the industry is still evolving.Chapters 00:00:00 Welcome to the Future of Longevity Clinics 00:02:35 Thailand: The Global Hub for Longevity Treatment 00:05:26 Understanding Stem Cell Therapies 00:09:13 The Rise of IV Drip Bars 00:13:05 Laser Treatments and Aesthetic Dermatology 00:15:58 The Brotox Movement: Men Embracing Aesthetics 00:19:21 What Thailand...

Why Eating Less Slows Aging | Caloric Restriction & Longevity with Dr. Rozalyn Anderson

30 min

Episode 4 In this episode of the Reprogram Podcast, Dr. George Murphy hosts Dr. Rozalyn Anderson, a leading expert in caloric restriction and metabolism and how they impact healthful aging. They delve into the science of aging, focusing on caloric restriction and its impact on longevity. Dr. Anderson shares her journey from yeast genetics to studying aging in animal models, and finally, to applying what was learned to humans, highlighting the metabolic processes that contribute to aging and how caloric restriction can delay age-related diseases. The discussion also covers the potential of geroprotectors like rapamycin, the possibilities of radical age reversal, and how we should train the next generation of scientists and clinicians. Keywords caloric restriction, aging, metabolism, longevity, geroprotectors, rapamycin, geroscience, regenerative medicine, aging biology, gerontology Takeaways Caloric restriction is the gold standard for studying longevity interventions.Metabolism plays a crucial role in aging processes.Caloric restriction can delay the onset of age-related diseases.Rapamycin shows promise as a geroprotector.Energy efficiency is key to metabolic resilience.Human trials like CALERIE align with animal studies on aging.Methylation clocks offer insights into biological age.Functional outcomes are vital in aging research.Geroprotectors aim to offset age-related conditions.Collaboration between academia and industry is essential.Office Artifact On the desk: The Mongkhon or Muay Thai Headband traditionally worn by Thai martial artist as they enter the ring. Bangkok, Thailand Chapters 00:00:00 Introduction to Dr. Rozalyn Anderson and Caloric Restriction 00:03:04 Understanding Caloric Restriction 00:06:44 We Are What We Eat! 00:08:38 Caloric Restriction as the “Gold Standard’ of Slowing Aging 00:10:03 Rapamycin as a Longevity Intervention 00:11:30 Exploring Geroprotectors 00:14:48 What is Aging and How Do We Measure It? 00:16:40 Defining Geroprotection and Lo...

What Centenarians Teach Us About Living Longer | Dr. Tom Perls

55 min

Episode 3 In this episode of the Reprogram podcast, Dr. George Murphy hosts Dr. Tom Perls, a leading expert in human exceptional longevity. They discuss Dr. Perls' journey into gerontology, the New England Centenarian Study, and the factors contributing to exceptional longevity. The conversation covers the genetic and environmental influences on aging, the role of centenarians in understanding longevity, and practical advice for living a centenarian-like life. Keywords longevity, centenarians, aging, health, resilience, exceptional aging, gerontology, aging research, genetics, healthspan Takeaways Dr. Tom Perls shares his journey into gerontology and exceptional longevity.The New England Centenarian Study is the largest study of centenarians and their families.Centenarians often defy the expectation that older age equates to poorer health.The majority of centenarians are female, with unique resilience against age-related diseases.Genetic and environmental factors both play significant roles in longevity.The concept of 'escapers' who avoid age-related diseases is explored.Dr. Perls introduces the 'Sageing' acronym for healthy aging practices.Lifestyle choices can influence longevity and healthspan.The potential for future therapeutics to extend life is discussed.Avoid smoking and anti-aging quackery for better health.Optimism about aging can motivate healthier choices. Office Artifact On the desk: Original artwork composed of rolled magazine pages, Bali, Indonesia Chapters 00:00 Introduction to Longevity and Exceptional Aging 01:07 Dr. Perls’ Journey into Gerontology and Exceptional Longevity 05:57 Defining Exceptional Longevity 08:49 Gender Differences in Centenarians14:50 The Centenarian Boom and Population Trends 19:53 Stratifying Centenarians: Survivors, Delayers, and Escapers 25:28 Genetics vs. Environment in Longevity32:23 Becoming Centenarian-like 37:07 The SAGEING framework for Healthy Aging 45:40 Anti-aging Quackery 48:23 Future of Longevity Science 52:41...

What Is Aging—And Can Science Really Reverse It?

13 min

Episode 2 In this episode of the Reprogram podcast, Dr. George Murphy explores the enigmatic topic of aging, discussing its definitions, cultural significance, and the latest scientific advancements aimed at understanding and potentially reversing the aging process. The conversation delves into the historical obsession with aging, the current state of research, and the implications of emerging therapies. Keywords aging, science, medicine, longevity, epigenetics, biological clocks, senescence, gene therapy, regenerative medicine, immortality, geroscience Takeaways Aging is a complex and mysterious process and is defined variably by different scientists.Modern science is exploring senolytic drugs and gene therapies.The hallmarks of aging provide a framework for understanding the process.Biological aging clocks are a tool for measuring age.Epigenetics play a key role in how we age.Aging is a universal process affecting everyone.Research is ongoing to find ways to slow or reverse aging.Age reversal is possible at the cellular level, but is not yet a reality for humans. Office Artifact On the desk: Ostrich egg from South Africa Chapters 00:00 The Mystery of Aging 03:01 Understanding Aging: Damage Accumulation and Resilience 06:10 The Hallmarks of Aging 08:54 Epigenetics: The Key to Biological Age 12:11 Age Reversal: Resetting the Slinky Notes: Seminal Hallmarks of Aging Paper: https://pubmed.ncbi.nlm.nih.gov/23746838/

Stem Cells & Regenerative Medicine: What the Science Actually Supports

47 min

Episode 1 In this episode of the Reprogram podcast, Dr. George Murphy and Dr. Gustavo Mostoslavsky delve into the world of stem cells and regenerative medicine. They discuss the fundamental properties of stem cells, their classifications, and the controversies surrounding their use in treatments. The conversation highlights the groundbreaking discovery of induced pluripotent stem cells (iPSCs) and their potential therapeutic applications, as well as the emerging field of organoids. The episode emphasizes the importance of understanding the science behind stem cells, the ethical implications, and the need for patience as research progresses towards practical applications. Keywords stem cells, regenerative medicine, iPSCs, pluripotent, adult stem cells, Shinya Yamanaka, bioartificial organs, stem cell tourism, gene editing, organoids Takeaways Stem cells have two main properties: self-renewal and differentiation.Adult stem cells are found in tissues and organs, while pluripotent stem cells can become any cell type.iPSCs were discovered by Dr. Shinya Yamanaka, revolutionizing stem cell research.Ethical concerns exist around embryonic stem cells, but iPSCs offer a non-controversial alternative.Stem cell tourism exploits desperate patients with unproven treatments; Education and awareness are crucial to avoid falling for stem false claims.Organoids are miniaturized and simplified versions of organs created in vitro.iPSCs are used for disease modeling and have potential therapeutic applications.Gene editing, like CRISPR, is advancing stem cell research.Bioartificial organs could solve organ transplant shortages in the future.The field of stem cell research is rapidly advancing, with many clinical trials underway; The future of stem cell research holds promise for transformative therapies, but patience is needed. Chapters 00:00 Introduction to Stem Cells and Regenerative Medicine 02:21 Defining Stem Cells: Properties and Classifications 07:52 Controversies in Stem Cell T...

Introducing The ReProgram Podcast

6 min

Episode 0 In the premier episode of The ReProgram podcast, Dr. George Murphy introduces the concept of reprogramming oneself for resilience against disease and disability. He shares his existential crisis about focusing on disease treatment rather than prevention, leading to a new approach centered on studing dynamic resilience, or our ability to robustly respond to insult and injury. The episode also outlines topics for future discussions, including the history and use of stem cells in regenerative medicine, exceptional longevity and centenarians, and the realities of age reversal. Keywords reprogramming, resilience, iPSCs, stem cells, disease prevention, dynamic resilience, centenarians, longevity, regenerative medicine, geroscience, age reversal Takeaways Reprogramming oneself can lead to resilience against disease.Focusing on disease prevention is more effective than treatment.Centenarians offer insights into exceptional longevity.Genes and mechanisms drive resilience to disease.Understanding aging is crucial before we can even begin to contemplate age reversal.The podcast explores longevity and geroscience. Office Artifact On the desk: Avengers Marvel Legends Full Scale Iron Man Electronic Helmet Chapters (00:00:00) Introduction to The ReProgram podcast (00:00:35) The Role of Master Stem Cells in Disease Modeling and Regenerative Medicine (00:01:58) Existential Crisis and a New Approach to Science and Medicine (00:04:22) Dynamic Resilience and Longevity (00:05:16) Future Topics and Explorations

–

0 ratings from members

5
4
3
2
1

Rate this podcast

Log in to rate and review the shows you listen to.

No reviews yet — be the first member to rate "The ReProgram".

This podcast, its content and its artwork are not owned by, affiliated with, or endorsed by Castquire.

Keep listening

Discover more podcasts like this.

Browse podcasts See the charts

Up next

  1. Nothing queued. Use + Queue on any episode to line it up.

0:00 0:00

Cookies

We set only what the site needs to sign you in and remember your theme. No advertising, no analytics. Read more.